Lazard US Equity Concentrated Portfolio (LEVIX)

1 member of Congress has disclosed 1 trade in Lazard US Equity Concentrated Portfolio (LEVIX) via STOCK Act filings. The most recent disclosure was a purchase by Harley Rouda on 28 May 2020. Aggregate disclosed activity totals roughly $8K in purchases (midpoint estimates from bracketed disclosure amounts).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Price data is not available for LEVIX
This ticker may have been delisted, renamed, or is not publicly quoted, so no live price, statistics or chart can be shown. The congressional trades disclosed for it are listed below.

Congressional Trading Activity for LEVIX

1 transactions
Compliance: 0%
Harley Rouda28 May 20204 May 2021PurchaseStock$1,001 - $15,000N/A

Stock Overview

Market Data

Market Cap

$1.43B

Volume

0

Beta

1.19

P/E Ratio

35.39

Fundamentals

EPS

$0.41

Div. Yield

-

Open

$14.59

Day Range

$14.59 – $14.59

Company Information

Sector
Financial Services
Industry
Asset Management
Exchange
NASDAQ · USD
Country
US
IPO Date
2005-10-03

The Lazard US Equity Concentrated Portfolio primarily allocates capital to common stocks of U.S.-based companies, spanning all market capitalizations. It maintains a highly focused investment approach, typically holding positions in a select group of...

No earnings data available for this stock.

Dividends

Dividend History

20 Dec 2024
Amount $5.6413
21 Dec 2023
Amount $6.8043
17 Aug 2023
Amount $1.7805
22 Dec 2022
Amount $0.0967
18 Aug 2022
Amount $0.3431
22 Dec 2021
Amount $2.7421
19 Aug 2021
Amount $0.2396
22 Dec 2020
Amount $0.2981
20 Aug 2020
Amount $0.0000
20 Dec 2019
Amount $0.1390
21 Dec 2018
Amount $1.1577
21 Aug 2018
Amount $0.3384
21 Dec 2017
Amount $1.0467
22 Dec 2016
Amount $0.6385
22 Aug 2016
Amount $0.0569
21 Dec 2015
Amount $0.5120
22 Dec 2014
Amount $1.0830
11 Aug 2014
Amount $0.4348
23 Dec 2013
Amount $1.2705
24 Dec 2012
Amount $0.0966
28 Dec 2011
Amount $0.1680
28 Dec 2010
Amount $0.0940
29 Dec 2009
Amount $0.1171
24 Aug 2009
Amount $0.0006
22 Dec 2008
Amount $0.1720
29 Sept 2006
Amount $0.0990
20 Dec 2005
Amount $0.0280

No stock split data available for this stock.

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations

Frequently Asked Questions about LEVIX

Which members of Congress have traded LEVIX?
1 member of Congress has disclosed 1 trade in Lazard US Equity Concentrated Portfolio (LEVIX) under the STOCK Act: Harley Rouda.
When was LEVIX most recently disclosed by Congress?
The most recent LEVIX disclosure was a purchase by Harley Rouda on 28 May 2020.
What is the total disclosed congressional trading volume for LEVIX?
Members of Congress have disclosed approximately $8K in LEVIX purchases (midpoint estimate derived from the bracketed amount ranges used in STOCK Act filings).
How can I track new congressional trades in LEVIX?
This LEVIX page updates as soon as new STOCK Act disclosures are filed for Lazard US Equity Concentrated Portfolio. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.